Establishment of tumor inflammasome clusters with distinct immunogenomic landscape aids immunotherapy
Open Access
- 1 January 2021
- journal article
- research article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 11 (20) , 9884-9903
Abstract
Inflammasome signaling is a reaction cascade that influences immune response and cell death. Although the inflammasomes participate in tumorigenesis, their role as an oncogenic booster or a tumor suppresser is still controversial. Therefore, it is important to comprehensively investigate the inflammasome signaling status across various cancers to clarify its clinical and therapeutic significance.Keywords
This publication has 71 references indexed in Scilit:
- Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic ValuePLOS Medicine, 2013
- MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancerImmunological Reviews, 2013
- Tumour inflammasome‐derived IL‐1β recruits neutrophils and improves local recurrence‐free survival in EBV‐induced nasopharyngeal carcinomaEMBO Molecular Medicine, 2012
- Mutation of plasma membrane Ca 2+ ATPase isoform 3 in a family with X-linked congenital cerebellar ataxia impairs Ca 2+ homeostasisProceedings of the National Academy of Sciences, 2012
- Krüppel-like factor 4 regulates macrophage polarizationJournal of Clinical Investigation, 2011
- Cell Surface Signaling Molecules in the Control of Immune Responses: A Tide ModelImmunity, 2011
- Expression of the Inhibitory CD200 Receptor Is Associated with Alternative Macrophage ActivationJournal of Innate Immunity, 2009
- De novo Induction of Genetically Engineered Brain Tumors in Mice Using Plasmid DNACancer Research, 2009
- Balance of Yin and Yang: Ubiquitylation-Mediated Regulation of p53 and c-MycNeoplasia, 2006
- The role of TCL1 in human T-cell leukemiaOncogene, 2001